Aquaflor by is a Animal medication manufactured, distributed, or labeled by Merck Sharp & Dohme Corp., Intervet GESMBH, MINSHENG GROUP SHAOXING PHARMACEUTICAL CO., LTD.. Drug facts, warnings, and ingredients follow.
Federal law limits this drug to use under the professional supervision of a licensed veterinarian. Animal feed bearing or containing this veterinary feed directive drug shall be fed to animals only by or upon a lawful veterinary feed directive (VFD) issued by a licensed veterinarian in the course of the veterinarian's professional practice.
Fish Species | Indication | Florfenicol (mg/kg body weight/day) | Florfenicol (grams/ton) |
---|---|---|---|
Caution: Not for use in animals intended for breeding purposes. The effects of florfenicol on reproductive performance have not been determined. Toxicity studies in dogs, rats, and mice have associated the use of florfenicol with testicular degeneration and atrophy. For catfish, a dose related decrease in hematopoietic/lymphopoietic tissue may occur. The time required for the hematopoietic/lymphopoietic tissues to regenerate was not evaluated. | |||
Freshwater-reared salmonids | For the control of mortality due to furunculosis associated with Aeromonas salmonicida. | 10 - 15 | 182-2,724 |
For the control of mortality due to coldwater disease associated with Flavobacterium psychrophilum. | |||
Freshwater-reared finfish | For the control of mortality due to columnaris disease associated with Flavobacterium columnare. | 10 - 15 | 182-2,724 |
Catfish | For the control of mortality due to enteric septicemia associated with Edwardsiella ictaluri. | 10 - 15 | 182-2,724 |
Freshwater-reared warmwater finfish | For the control of mortality due to streptococcal septicemia associated with Streptococcus iniae. | 15 | 273- 2,724 |
This product has been evaluated in salmonid and catfish feeds and should be used in feeds nutritionally similar to these evaluated feeds. Refer to the Freedom of Information Summary for details. Must be thoroughly mixed in feeds or surface-coated (top-coated) onto the feeds before use.
For making Aquaflor® (florfenicol) Type C Medicated Feed:
There are two methods for making Aquaflor® (florfenicol) Type C Medicated Feed by top-coating.
Method 1:
Method 2:
Feeding Rate | Florfenicol Concentration in Feed | Amount of Aquaflor® (florfenicol) per Ton of Feed | Biomass of Fish Medicated per Ton of Feed per 10-day Treatment Period | ||
---|---|---|---|---|---|
% Biomass | Grams/ton | lbs | lbs | ||
Dose 10 mg/kg | Dose 15 mg/kg | Dose 10 mg/kg | Dose 15 mg/kg | ||
0.5 | 1,816 | 2,724 | 8 | 12 | 40,000 |
1 | 908 | 1,362 | 4 | 6 | 20,000 |
2 | 454 | 681 | 2 | 3 | 10,000 |
3 | 300 | 450 | 1.32 | 1.98 | 6,666 |
5 | 182 | 273 | 0.8 | 1.2 | 4,000 |
Feed as the sole ration for 10 consecutive days. Aquaflor® (florfenicol) medicated feed should only be administered once disease has been appropriately diagnosed. Feeding fish at a percent of biomass and corresponding florfenicol concentration included in the table above will deliver the appropriate florfenicol dose.
Feed containing Aquaflor® (florfenicol) shall not be fed to finfish for more than 10 days. Following administration, fish should be re-evaluated by a licensed veterinarian before initiating a further course of therapy. The expiration date for VFD for Aquaflor® (florfenicol) must not exceed 15 days from the date of issuance. VFD for Aquaflor® (florfenicol) shall not be refilled.
Sunburn, skin lesions, and skin sloughing have been reported in salmonids treated with florfenicol. Not all adverse drug events are reported to FDA CVM. It is not always possible to reliably estimate the adverse event incidence or to establish a causal relationship to product exposure using this data alone.
Before using this drug for the first time, you must inform the appropriate National Pollutant Discharge Elimination System (NPDES) permitting authority of your intentions and of the following information. Acute and chronic water quality benchmarks for the protection of freshwater aquatic life have been derived by FDA for florfenicol following EPA guidance for calculating Tier II water quality criteria for the Great Lakes System (40 CFR 132, App. A). The acute benchmark value (Secondary Maximum Concentration) is 20.6 mg/L (equivalent to one-half of the Secondary Acute Value). The chronic benchmark value (Secondary Continuous Concentration) is 0.23 mg/L (equivalent to the Final Plant Value). The NPDES authority may require an NPDES permit before you can discharge Aquaflor®. The water quality benchmark concentrations are not discharge limits, but may be used by the NPDES authority to derive such limits for the permit. Additional environmental information on Aquaflor® and the benchmark values are available in an environmental assessment posted at http://www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/EnvironmentalAssessments/ucm300656.htm.
Avoid inhalation, oral exposure, and direct contact with skin or eyes. Operators mixing and handling Aquaflor® (florfenicol) should use protective clothing, gloves, goggles and NIOSH-approved dust mask. Wash thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse thoroughly with water. If irritation persists, seek medical attention. Not for human consumption. Keep out of reach of children. The Safety Data Sheet (SDS) contains more detailed occupational safety information. For more information or to report adverse effects, call 1-800-224-5318. For customer service, call 1-800-521-5767. For a copy of SDS sheet, call 1-800-770-8878.
2 kg (4.4 lb)
Aquaflor®
(Florfenicol)
Type A Medicated Article
For Use in Freshwater-reared Finfish Feeds Only
Do Not Feed Undiluted
CAUTION: Federal law restricts medicated feed containing this veterinary feed directive
(VFD) drug to use by or on the order of a licensed veterinarian.
Active Drug Ingredient: Florfenicol 500 g per kg (227.27 g per lb)
Description: Each kg of Aquaflor® (florfenicol) contains 500 g (1.1 lb)
of florfenicol in a palatable base.
NADA #141-246, Approved by FDA.
Copyright © 2013, 2015 Intervet Inc., a subsidiary of Merck & Co. Inc.
Madison, NJ 07940 USA
All rights reserved.
Made in Austria.
MERCK
Animal Health
156125 R2
AQUAFLOR
TYPE A MEDICATED ARTICLE
florfenicol powder |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Merck Sharp & Dohme Corp. (001317601) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Intervet GESMBH | 303380992 | MANUFACTURE |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
MINSHENG GROUP SHAOXING PHARMACEUTICAL CO., LTD. | 544607919 | API MANUFACTURE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AQUAFLOR 90885675 not registered Live/Pending |
TARKETT USA INC. 2021-08-16 |
AQUAFLOR 88013533 5674914 Live/Registered |
Bedoukian Research, Inc. 2018-06-25 |
AQUAFLOR 75631936 2458027 Live/Registered |
INTERVET INC. 1998-12-07 |
AQUAFLOR 74203177 not registered Dead/Abandoned |
Brita Limited 1991-09-13 |
AQUAFLOR 74055857 1778269 Dead/Cancelled |
Schering Corporation 1990-05-04 |
AQUAFLOR 73498925 1344757 Dead/Cancelled |
DOMCO INDUSTRIES LIMITED-LES INDUSTRIESDOMCO LIMITEE 1984-09-11 |